Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Bonds: Convertible Notes, Added, 2021 Q2

CITADEL ADVISORS LLC historic quarter change: USA Bonds: Convertible Notes, Added

In convertible notes that pay a coupon (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 1,005 positions, added to 266, reduced 334 and sold out of 965.

  • Q2 2021: Stock ZILLOW GROUP INC; Country of operation —; Class NOTE 1.375% 9/0; Principal before $114,750,000.
  • Q2 2021: Stock BILIBILI INC; Country of operation —; Class NOTE 1.375% 4/0; Principal before $54,000,000.
  • Q2 2021: Stock BRIDGEBIO PHARMA INC; Country of operation United States; Class NOTE 2.500% 3/1; Principal before $44,700,000.
  • Q2 2021: Stock ZILLOW GROUP INC; Country of operation —; Class NOTE 0.750% 9/0; Principal before $102,932,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassPrincipal beforePrincipal afterShare changeValue beforeValue afterValue changeFiled
Q2 2021ZILLOW GROUP INC
CUSIP 98954MAG6		—NOTE 1.375% 9/0$114,750,000$147,250,000+32,500,000$343,327$416,825+$73,4982021-08-16
Q2 2021BILIBILI INC
CUSIP 090040AB2		—NOTE 1.375% 4/0$54,000,000$60,506,000+6,506,000$234,080$297,765+$63,6852021-08-16
Q2 2021BRIDGEBIO PHARMA INC
CUSIP 10806XAB8		United StatesNOTE 2.500% 3/1$44,700,000$73,450,000+28,750,000$74,011$120,618+$46,6072021-08-16
Q2 2021ZILLOW GROUP INC
CUSIP 98954MAE1		—NOTE 0.750% 9/0$102,932,000$123,932,000+21,000,000$306,746$348,306+$41,5602021-08-16
Q2 2021GUESS INC
CUSIP 401617AD7		—NOTE 2.000% 4/1$7,000,000$29,000,000+22,000,000$8,066$36,140+$28,0742021-08-16
Q2 2021COLONY STARWOOD HOMES
CUSIP 19625XAB8		—NOTE 3.500% 1/1$64,582,000$69,493,000+4,911,000$91,504$113,882+$22,3782021-08-16
Q2 2021PEBBLEBROOK HOTEL TR
CUSIP 70509VAA8		—NOTE 1.750%12/1$49,631,000$70,631,000+21,000,000$58,513$80,370+$21,8572021-08-16
Q2 2021PEGASYSTEMS INC
CUSIP 705573AB9		—NOTE 0.750% 3/0$24,000,000$39,500,000+15,500,000$26,320$47,313+$20,9932021-08-16
Q2 2021GDS HLDGS LTD
CUSIP 36165LAB4		—NOTE 2.000% 6/0$97,500,000$110,965,000+13,465,000$163,977$182,379+$18,4022021-08-16
Q2 2021GREEN PLAINS INC
CUSIP 393222AK0		United StatesNOTE 2.250% 3/1$9,500,000$21,484,000+11,984,000$10,674$27,708+$17,0342021-08-16
Q2 2021VEONEER INC
CUSIP 92336XAA7		—NOTE 4.000% 6/0$22,000,000$36,280,000+14,280,000$29,151$45,925+$16,7742021-08-16
Q2 2021ATLAS AIR WORLDWIDE HLDGS IN
CUSIP 049164BJ4		—NOTE 1.875% 6/0$27,500,000$37,500,000+10,000,000$33,119$47,856+$14,7372021-08-16
Q2 2021INFINERA CORP
CUSIP 45667GAE3		—NOTE 2.500% 3/0$41,000,000$47,000,000+6,000,000$60,176$71,605+$11,4292021-08-16
Q2 2021SMART GLOBAL HLDGS INC
CUSIP 83205YAB0		—NOTE 2.250% 2/1$68,379,000$73,379,000+5,000,000$90,426$101,088+$10,6622021-08-16
Q2 2021CYTOKINETICS INC
CUSIP 23282WAA8		—NOTE 4.000%11/1$40,050,000$51,050,000+11,000,000$95,277$105,552+$10,2752021-08-16
Q2 2021CENTENNIAL RESOURCE DEV INC
CUSIP 15136AAA0		—NOTE 3.250% 4/0$9,000,000$14,100,000+5,100,000$8,631$18,754+$10,1232021-08-16
Q2 2021NEOGENOMICS INC
CUSIP 64049MAB6		—NOTE 0.250% 1/1$20,000,000$30,000,000+10,000,000$20,239$29,388+$9,1492021-08-16
Q2 2021LIBERTY MEDIA CORP DEL
CUSIP 531229AB8		—NOTE 1.375%10/1$84,500,000$86,931,000+2,431,000$107,793$116,057+$8,2642021-08-16
Q2 2021GRANITE CONSTR INC
CUSIP 387328AB3		—NOTE 2.750%11/0$49,000,000$51,500,000+2,500,000$68,212$74,832+$6,6202021-08-16
Q2 2021SAREPTA THERAPEUTICS INC
CUSIP 803607AB6		—DBCV 1.500%11/1$67,497,000$70,497,000+3,000,000$88,265$93,227+$4,9622021-08-16
Q2 2021KARYOPHARM THERAPEUTICS INC
CUSIP 48576UAA4		—NOTE 3.000%10/1$48,300,000$53,300,000+5,000,000$50,405$53,128+$2,7232021-08-16
Q2 2021KAMAN CORP
CUSIP 483548AF0		—NOTE 3.250% 5/0$29,086,000$30,322,000+1,236,000$31,510$32,281+$7712021-08-16
Q2 2021IMPINJ INC
CUSIP 453204AA7		—NOTE 2.000%12/1$34,640,000$37,200,000+2,560,000$62,460$62,079-$3812021-08-16
Q2 2021AIR TRANSPORT SERVICES GRP I
CUSIP 00922RAB1		—NOTE 1.125%10/1$26,396,000$29,396,000+3,000,000$29,752$29,986+$2342021-08-16